Viewing Study NCT00130403


Ignite Creation Date: 2025-12-24 @ 7:21 PM
Ignite Modification Date: 2026-01-29 @ 8:35 AM
Study NCT ID: NCT00130403
Status: COMPLETED
Last Update Posted: 2011-01-11
First Post: 2005-08-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women
Sponsor: Sanofi
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Osteoporosis, Postmenopausal View
Keywords: